A5007185434- Breast Cancer Treatment Studies
- Venous Thromboembolism Diagnosis and Management
- Cancer Treatment and Pharmacology
- Breast Lesions and Carcinomas
- Central Venous Catheters and Hemodialysis
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Systems and Practices
- Advanced Breast Cancer Therapies
- Cancer and Skin Lesions
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Reproductive Health and Contraception
- Cancer Cells and Metastasis
- Economic and Financial Impacts of Cancer
- Radiation Dose and Imaging
- Probabilistic and Robust Engineering Design
- Reproductive Biology and Fertility
- Radioactive Decay and Measurement Techniques
- Mechanical Circulatory Support Devices
- Breastfeeding Practices and Influences
- Mathematics, Computing, and Information Processing
- Metastasis and carcinoma case studies
- Infant Nutrition and Health
- Clinical practice guidelines implementation
- Radiation Therapy and Dosimetry
Centre hospitalier Robert-Ballanger
2022-2025
Hôpital Saint-Louis
2005-2022
Assistance Publique – Hôpitaux de Paris
2011-2022
Inserm
2014
Institut de Recherche Vaccinale
2014
Université Paris-Est Créteil
2014
Université Paris Cité
2011
Introduction Breast cancer is a global public health challenge. It the most commonly diagnosed and leading cause of cancer-related death in women. Several inequalities remain among women facing this disease, depending on their country birth sociodemographic characteristics. The SENOVIE study (Therapeutic mobility breast cancer) aims to understand life trajectories born France sub-Saharan Africa treated for four hospitals greater Paris area. Methods analysis mixed methods study, combining...
Background: Patients with triple-negative breast cancers (TNBC) have a poor prognosis unless pathological complete response (pCR) is achieved after neoadjuvant chemotherapy (NAC). Few studies analyzed changes in TIL levels following dose-dense dose-intense (dd-di) NAC. and methods: From 2009 to 2018, 117 patients TNBC received dd-di NAC at our institution. We aimed identify factors associated pre- post-NAC levels, oncological outcomes relapse-free survival (RFS), overall (OS). Results:...
Inflammatory breast cancers are very aggressive, and among them, triple negative cancer (TNBC) has the worst prognosis. While many studies have investigated association between tumor-infiltrating lymphocytes (TIL) before neoadjuvant chemotherapy (NAC) outcome in TNBC, impact of post-NAC TIL variation inflammatory (TNIBC) is unknown. Between January 2010 to December 2018, all patients with TNIBC seen at disease unit (Saint-Louis Hospital) were treated dose-dense dose-intense NAC. The main...
Abstract Background: Breast cancer screening increases the detection of nonpalpable breast lesions, These lesions raise specific concerns, involving radiological imaging, biopsy techniques, and pathological analysis. The objective study is to evaluate management in a disease unit.Material Methods: From 2001 2007, 2708 were prospectively evaluated by multidisciplinary team. Radiologic detected mammography alone (71,5%), ultrasonography (27,90%), MRI (0,20%). All classified according BI RADS...
9044 Background: Due to the frequency of breast cancer, and high proportion premenopausal women, contraception in survivors is a major concern. In contrast, literature data are dramatically nonexistent. Classical options included local methods, copper or hormonal (LNG) intrauterine devices (IUD). Little known about use estroprogestins progestative only contraception. The aim this survey describe French current practice regarding after cancer. Methods: A retrospective study was conducted...
10729 Background: Neoadjuvant chemotherapy is increasingly used in locally advanced breast cancer ptes. We studied the histological response after neoadjuvant ptes with and inflammatory cancer. Methods: From 2003 to 2005, 50 received (Epirubicin 75 mg/m 2 , Cyclophosphamide 750 (d1-q21, 4 courses (c)) followed by Docetaxel 100 c). All had a surgical biopsy prior chemotherapy, initial conservative surgery was impossible. Clinical responses were evaluated same oncologist slices reviewed...